|
| Status |
Public on May 28, 2020 |
| Title |
MV-4-11 control B |
| Sample type |
SRA |
| |
|
| Source name |
MV-4-11 control
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: MV-4-11
cell type: acute myeloid leukemia (AML) cell line
treatment: none (control)
|
| Extracted molecule |
polyA RNA |
| Extraction protocol |
RNA was harvested using TRIzol reagent.
Libraries were prepared from polyA-enriched RNA by standard Illumina protocols.
|
| |
|
| Library strategy |
RNA-Seq |
| Library source |
transcriptomic |
| Library selection |
cDNA |
| Instrument model |
Illumina HiSeq 3000 |
| |
|
| Description |
3404-SH-16
|
| Data processing |
Read alignment performed with TopHat
Differential gene expression determined by CuffdiffÂ
Genome_build: hg19
Supplementary_files_format_and_content: plain text documents containing averaged RPKM values and calculated differential expression between treatment samples and corresponding control samples
|
| |
|
| Submission date |
Feb 11, 2020 |
| Last update date |
May 28, 2020 |
| Contact name |
Scott Hiebert |
| Organization name |
Vanderbilt University
|
| Street address |
2220 Pierce Ave.
|
| City |
Nashville |
| State/province |
TN |
| ZIP/Postal code |
37232 |
| Country |
USA |
| |
|
| Platform ID |
GPL21290 |
| Series (1) |
| GSE145106 |
RNA-seq of MV-4-11 or THP-1 cells treated with LSD1 inhibitor INCB059872 |
|
| Relations |
| BioSample |
SAMN14083827 |
| SRA |
SRX7708130 |
